Antihemophilic Factor

This page contains recent news articles, when available, and an overview of Antihemophilic Factor but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Overview:

Antihemophilic Factor (when available)

Pharmacology and use:
Binds factor IXa along with calcium and phospholipid, This complex converts factor X to factor Xa to facilitate clotting cascade. For treatment of hemophilia A, von Willebrand diseae, Factor XIII deficiency

Mechanism Of Action:
Not Available

News Articles on Antihemophilic Factor

Junior Athletes Honored by CSL Behring at National Hemophilia Foundation's ... - ‎Oct 29, 2009‎
Developed by CSL Behring, provider of the hemophilia treatment Helixate FS (Antihemophilic Factor, Recombinant), the JNC is a series of one-day events held ... The FINANCIAL

Brand Names/Synonyms:
Antihemophilic Factor is also known by the following brand names and/or synonymsCoagulation factor VIII precursor;Procoagulant component;Antihemophilic factor;AHF; Human recombinant antihemophilic factor (AHF) or Factor VIII, 2332 residues, glycosylated, produced by CHO cells

Drug Category:
Antihemophilic Factor is categorized under the following by the FDA: Coagulants; Thrombotic Agents; hemostatics (20:12.16)

Dosage Forms:
POWDER FOR SOLUTION

Absorption:
Not Available

Interactions:
Not Available

Chemical IUPAC Name:
Not Available

Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.